| Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity M Romano, G Fanelli, CJ Albany, G Giganti, G Lombardi Frontiers in immunology 10, 43, 2019 | 556 | 2019 |
| Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies KS Saini, M Tagliamento, M Lambertini, R McNally, M Romano, M Leone, ... European journal of cancer 139, 43-50, 2020 | 369 | 2020 |
| Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation A Sánchez‐Fueyo, G Whitehouse, N Grageda, ME Cramp, TY Lim, ... American Journal of Transplantation 20 (4), 1125-1136, 2020 | 173 | 2020 |
| An atlas of human regulatory T helper-like cells reveals features of Th2-like Tregs that support a tumorigenic environment L Halim, M Romano, R McGregor, I Correa, P Pavlidis, N Grageda, ... Cell reports 20 (3), 757-770, 2017 | 160 | 2017 |
| Treg therapy in transplantation: a general overview M Romano, SL Tung, LA Smyth, G Lombardi Transplant International 30 (8), 745-753, 2017 | 156 | 2017 |
| Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years F Palandri, N Polverelli, D Sollazzo, M Romano, L Catani, M Cavo, ... American Journal of Hematology 91 (4), E267-E272, 2016 | 107 | 2016 |
| Human retinoic acid–regulated CD161+ regulatory T cells support wound repair in intestinal mucosa GAM Povoleri, E Nova-Lamperti, C Scottà, G Fanelli, YC Chen, PD Becker, ... Nature immunology 19 (12), 1403-1414, 2018 | 101 | 2018 |
| Immunological considerations and challenges for regenerative cellular therapies S Petrus-Reurer, M Romano, S Howlett, JL Jones, G Lombardi, ... Communications biology 4 (1), 798, 2021 | 86 | 2021 |
| Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells C Scottà, G Fanelli, SJ Hoong, M Romano, EN Lamperti, M Sukthankar, ... Haematologica 101 (1), 91, 2016 | 86 | 2016 |
| IL-36 promotes systemic IFN-I responses in severe forms of psoriasis M Catapano, M Vergnano, M Romano, SK Mahil, SE Choon, AD Burden, ... Journal of Investigative Dermatology 140 (4), 816-826. e3, 2020 | 85 | 2020 |
| Expanded regulatory T cells induce alternatively activated monocytes with a reduced capacity to expand T helper-17 cells M Romano, G Fanelli, N Tan, E Nova-Lamperti, R McGregor, RI Lechler, ... Frontiers in immunology 9, 1625, 2018 | 78 | 2018 |
| Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice V Salvestrini, R Zini, L Rossi, S Gulinelli, R Manfredini, E Bianchi, ... Blood, The Journal of the American Society of Hematology 119 (1), 217-226, 2012 | 62 | 2012 |
| PD-L1 signaling on human memory CD4+ T cells induces a regulatory phenotype G Fanelli, M Romano, E Nova-Lamperti, MW Sunderland, A Nerviani, ... PLoS biology 19 (4), e3001199, 2021 | 60 | 2021 |
| Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy KS Saini, C Lanza, M Romano, E de Azambuja, J Cortes, B de Las Heras, ... British journal of cancer 123 (5), 694-697, 2020 | 46 | 2020 |
| Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis M Romano, D Sollazzo, S Trabanelli, M Barone, N Polverelli, M Perricone, ... Oncoimmunology 6 (10), e1345402, 2017 | 46 | 2017 |
| The choice of second‐line therapy in steroid‐resistant immune thrombocytopenia: Role of platelet kinetics in a single‐centre long‐term study F Palandri, N Polverelli, L Catani, D Sollazzo, M Romano, M Levorato, ... American Journal of Hematology 89 (11), 1047-1050, 2014 | 39 | 2014 |
| Cancer treatment and research during the COVID-19 pandemic: experience of the first 6 months B de Las Heras, KS Saini, F Boyle, F Ades, E de Azambuja, ... Oncology and therapy 8, 171-182, 2020 | 35 | 2020 |
| The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis M Barone, L Catani, F Ricci, M Romano, D Forte, G Auteri, D Bartoletti, ... Oncoimmunology 9 (1), 1782575, 2020 | 31 | 2020 |
| Circulating calreticulin is increased in myelofibrosis: correlation with interleukin‐6 plasma levels, bone marrow fibrosis, and splenomegaly D Sollazzo, D Forte, N Polverelli, M Perricone, M Romano, S Luatti, ... Mediators of inflammation 2016 (1), 5860657, 2016 | 29 | 2016 |
| Crucial factors of the inflammatory microenvironment (IL-1β/TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study D Sollazzo, D Forte, N Polverelli, M Romano, M Perricone, L Rossi, ... Oncotarget 7 (28), 43974, 2016 | 26 | 2016 |
